Non-Hallucinogenic DMT? Psilera Bioscience Reports Progress on ‘Well-Tolerated’ Derivative
Further in vivo studies with PSIL-002 will evaluate its antidepressant, anxiolytic, and anti-addictive properties, specifically targeting alcohol consumption.
dmt
-
-
DEA Boosts Psychedelics Production (Again) to Meet Research Demand
Drug Enforcement Agency also addresses concerns from Native American Church regarding peyote poaching for mescaline research.
-
DEA Quadruples Psilocybin Manufacturing for Research in Final 2021 Production Quotas
Drug Enforcement Agency also hugely boosts MDMA and DMT quotas “in response to the nationwide public interest in hallucinogenic controlled substances research.”
-
Psychedelic Business Spotlight: October 22
This week in psychedelic business news: UK fast tracks DMT for major depressive disorder; Field Trip Health expands its clinical presence in the US; and another psychedelic pharmaceuticals company prepares for the Nasdaq.
-
How Mindset Pharma Is Making and Defining ‘Next-Generation Psychedelic Drugs’
CEO James Lanthier compares psychedelic medicines to aspirin, and explains why the company’s lead candidate may be better than psilocybin.
-
Seattle Decriminalizes Natural Psychedelics
Seattle City Council unanimously approves a resolution declaring entheogen-related activities should be among lowest law enforcement priorities.
-
World’s Richest Person Elon Musk: ‘People Should Be Open to Psychedelics’
The Tesla and SpaceX founder, estimated to be worth nearly $200 billion, has previously hinted at using DMT.
-
How Cybin Is ‘Revolutionizing’ Mental Healthcare with Novel Psychedelic Compounds
CEO Doug Drysdale explains several key factors in making psychedelic-assisted therapy accessible for the millions of people suffering around the globe.
-
Psychedelic Business Spotlight: September 24, 2021
This week in psychedelic business news: two patents may revolutionize the medical application of psychedelic compounds; DMT and ibogaine clinical trials show promise; and stock news for psychedelic investors.
-
How Mind Medicine Australia Is Tackling Deadly Mental Health Crisis with Psychedelics
Charity co-founder Tania de Jong says Covid-19 pandemic has led to “a huge spike in mental health issues including, very sadly, suicides,” and she believes psychedelics are a solution.
